Journal of the American Society of Nephrology · 2000 · 61 citations · 24 references
PharmacyPharmacokineticsPharmacologyRenal PathophysiologyRenal PharmacokineticsRenal PharmacotherapyDiuretic TherapyNephrotic SyndromePharmacokinetics In Renal ImpairmentRenal DiseaseRenal PharmacologyUrinary ExcretionAnimal Disease ModelsDiuretic MechanismsDiuretic ResistanceFractional Excretion Of SodiumNephrotic Syndrome TreatmentRenal DrugsSubstance ExcretionUrinary Sodium Excretion
Response to loop diuretics in patients with nephrotic syndrome (NS) is subnormal. Studies in animal models of NS have suggested that binding of diuretic to urinary albumin is one of the mechanisms that may be operative in this diuretic resistance. To explore this hypothesis, 12 patients with NS were studied to determine whether displacement from urinary protein binding with sulfisoxazole would restore response to 120 mg of furosemide. The study was stopped after treating seven patients because it was clear that sulfizoxazole had no effect. Sodium excretion (mean +/- SD) from furosemide alone was 239 +/- 90 versus 240 +/- 115 mEq/8 h with sulfisoxazole. Sulfisoxazole had modest effects on serum pharmacokinetics of furosemide but had no effect on either the time course of furosemide urinary excretion or overall amount excreted: 49 +/- 15 mg versus 54 +/- 12 mg for furosemide alone and furosemide plus sulfisoxazole, respectively. It is concluded that urinary protein binding of loop diuretics is not a major mechanism for the diuretic resistance of NS. In turn, strategies aimed at displacing such binding are unlikely to be clinically helpful.
24
Coadministration of albumin and furosemide in patients with the nephrotic syndrome
Danilo Fliser, Ines Zurbrüggen, E. Mutschler et al. · Kidney International · 1999 · 156 citations
Pharmacodynamic analysis of the furosemide-probenecid interaction in man
Polavat Chennavasin, Ruth Seiwell, D. Craig Brater et al. · Kidney International · 1979 · 127 citations